GlycoDisplay ApS
CVR 38218603 · Private limited company (ApS) · Active · Low risk
GlycoDisplay ApS is a Private limited company (ApS), founded on , based in København N. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.9% over the next 12 months, which is 0.6 times the average for Danish companies. 9 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK -1.1m and a net result of DKK 104k. CEO: Henrik Clausen.
Bankruptcy risk for GlycoDisplay ApS
0.6 × the average (1.41%) · higher risk than 70% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 38218603
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (9 years)
- Address
- Blegdamsvej 3
2200 København N - Municipality
- København
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 100k
- Employees
- 1 (2018)
- Auditor
- CENTRUM REVISION Registrerede revisorer
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 1 of 9 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -160.1% |
| Current ratio | 1,157% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 1 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 3 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 179k | DKK -277k |
| Net profit | DKK 104k | DKK -246k |
| Equity | DKK -1.1m | DKK -1.2m |
| Total assets | DKK 693k | DKK 644k |
| Cash | DKK 87k | – |
| Short-term debt | DKK 60k | – |
| Tax owed | DKK 0 | – |
| Avg. employees | 1 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · CENTRUM REVISION Registrerede revisorer.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 166 | ||
| 1 Jan 2024 – 31 Dec 2024 | 142 | ||
| 1 Jan 2023 – 31 Dec 2023 | 148 | ||
| 1 Jan 2022 – 31 Dec 2022 | 163 | ||
| 1 Jan 2021 – 31 Dec 2021 | 167 | ||
| 1 Jan 2020 – 31 Dec 2020 | 182 | ||
| 1 Jan 2019 – 31 Dec 2019 | 205 | Late | |
| 1 Jan 2018 – 31 Dec 2018 | 147 | ||
| 30 Nov 2016 – 31 Dec 2017 | 150 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Henrik Clausen | Current | |
| CEO | Claus Kristensen | ||
| Owner (10%) | Zhang Yang | Current | |
| Owner (10%) | Yoshiki Narimatsu | Current | |
| Owner (50%) | GLYCOZYM ApS | Current | |
| Owner (5%) | GeCo ApS | Current | |
| Owner (10%) | Mandel & Clausen Holding ApS | Current | |
| Owner (10%) | Anceli Holding ApS | Current | |
| Founder | Zhang Yang | Current | |
| Founder | Yoshiki Narimatsu | Current | |
| Founder | GLYCOZYM ApS | Current | |
| Founder | GeCo ApS | Current | |
| Founder | Mandel & Clausen Holding ApS | Current | |
| Founder | Anceli Holding ApS | Current |
The CEOs' other companies
Henrik Clausen – 2 other companies
- GLYCOZYM ApS Active
- Mandel & Clausen Holding ApS Active
Claus Kristensen – 1 other companies
- Anceli Holding ApS Opløst
Address history (0 moves)
| Blegdamsvej 3, 2200 København N |
Employees per year
Other companies at the same address
- AKADEMISK BOGHANDEL FOND Bankrupt
- DEN SELVEJENDE INSTITUTION ODONTOLOGISK BOGHANDEL Bankrupt
- Genetwics IVS Opløst
Similar companies in København
- CARLSBERG A/S København V
- CuraVision ApS København V
- Launch Bioindustries ApS København Ø
- RheumaLogics ApS København Ø
- Vitibiotech ApS København N
- Pyovita ApS Hellerup
- ArcanaBio ApS København N
- OvartiX ApS København N
- Keystone Consulting ApS København SV
- KPL ApS København N
- Alveus Therapeutics ApS København K
- Cambiotics ApS København N
Questions and answers about GlycoDisplay ApS
Has GlycoDisplay ApS gone bankrupt?
No, GlycoDisplay ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of GlycoDisplay ApS?
Our model estimates a bankruptcy risk of 0.9% over the next 12 months (low risk), which is 0.6 times the average for Danish companies.
Who is the CEO of GlycoDisplay ApS?
Henrik Clausen is the CEO of GlycoDisplay ApS.
Who is the auditor of GlycoDisplay ApS?
GlycoDisplay ApS most recently used CENTRUM REVISION Registrerede revisorer.
When was GlycoDisplay ApS founded?
GlycoDisplay ApS was founded on 30 November 2016.
What is the equity of GlycoDisplay ApS?
Equity was DKK -1.1m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.